These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1189808)

  • 1. [Determination of the nucleolar coefficient in lymphocytes in chemotherapeutically treated patients with ovarian carcinoma].
    Jandrová A; Laurová L; Skoda V; Trnka V
    Zentralbl Bakteriol Orig B; 1975; 91(9):549-51. PubMed ID: 1189808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological changes in the nucleoli of peripheral-blood lymphocytes as prognostic criteria in the chemotherapy of malignant tumors.
    Matĕjoková E; Smetana K
    Neoplasma; 1975; 22(3):303-12. PubMed ID: 1174261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of the immunoglobin level in the serum of patients with ovarian neoplasms].
    Laurová L; Jandová A; Skoda VI; Zizkovská E; Zizkovský V
    Zentralbl Bakteriol Orig B; 1975; 91(9):540-8. PubMed ID: 1189807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood lymphocyte nucleoli of rats with Yoshida ascitic sarcoma and the effect of cyclophosphamide.
    Matĕjková E
    Folia Biol (Praha); 1975; 21(5):349-53. PubMed ID: 1201807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytembena and cyclophosphamide in the treatment of advanced neoplasias of the digestive tract (author's transl)].
    Matĕjková E; Rezábek K; Polák E
    Cesk Gastroenterol Vyz; 1974 Jul; 28(4):279-85. PubMed ID: 4603038
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on ring shaped nucleoli and micronucleoli of human peripheral lymphocytes.
    Raska I; Novák J; Smetana K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(2):185-92. PubMed ID: 6159257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs.
    Kopeć J; Sitarska E; Leszko B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):481-7. PubMed ID: 6670918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on nucleoli in rosetting T and B lymphocytes of the human peripheral blood.
    Smetana K; Lejnar J; Sálková J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(5):720-7. PubMed ID: 6162738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy.
    Matĕjková E; Vlastiborová A
    Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of combined administration of cytembena and cyclophosphamide on the blood count and morphology of nucleoli in peripheral-blood lymphocytes in patients with malignant tumors.
    Matĕjková E
    Neoplasma; 1975; 22(1):45-54. PubMed ID: 1173938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of inflammatory rheumatic diseases using cytembena].
    Hándlová D; Vojtísek O; Králová M; Brémová A; Kanková D; Pavelka K
    Fysiatr Revmatol Vestn; 1972 Oct; 50(5):278-83. PubMed ID: 4538713
    [No Abstract]   [Full Text] [Related]  

  • 13. To the nucleolar bodies (nucleoli) in cells of the lymphocytic lineage in patients suffering from B - chronic lymphocytic leukemia.
    Smetana K; Karban J; Trneny M
    Neoplasma; 2010; 57(6):495-500. PubMed ID: 20845986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunosuppressive effect of Cytembena in rheumatoid arthritis (author's transl)].
    Truhlár P; Matl I
    Cas Lek Cesk; 1975 Jan; 114(5):150-2. PubMed ID: 1120331
    [No Abstract]   [Full Text] [Related]  

  • 15. Nucleoli of peripheral blood lymphocytes in patients with chronic lymphocytic leukemia.
    Kopeć J; Sitarska E; Leszko B
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):685-90. PubMed ID: 6163415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of incorporation of labelled cyclophosphamide cytembena into human tumour.
    Jandová A; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4765907
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of incorporation of labelled cyclophosphamide and cytembena into human tumour.
    Jandov A ; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4725516
    [No Abstract]   [Full Text] [Related]  

  • 18. [Unusual nucleolar types in lymphocytes of inflammatory joint exudates].
    Smetana K; Stĕpán M; Mícánková M
    Z Rheumatol; 1981; 40(2):93-6. PubMed ID: 7282108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Registration of cytostatic effects on cultured cells in vitro and their current significance for individualized chemotherapy of tumors in advanced ovarian carcinoma].
    Ebeling K; Spitzbart H
    Zentralbl Gynakol; 1977; 99(17):1041-54. PubMed ID: 579017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with advanced ovarian carcinoma treated with Penberol.
    Novotná J; Andrysek O; Kobilková J; Laurová L
    Neoplasma; 1983; 30(2):245-50. PubMed ID: 6302531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.